255 related articles for article (PubMed ID: 22488933)
1. Endothelial progenitor cells in diabetes mellitus.
Menegazzo L; Albiero M; Avogaro A; Fadini GP
Biofactors; 2012; 38(3):194-202. PubMed ID: 22488933
[TBL] [Abstract][Full Text] [Related]
2. Potential manipulation of endothelial progenitor cells in diabetes and its complications.
Fadini GP; Avogaro A
Diabetes Obes Metab; 2010 Jul; 12(7):570-83. PubMed ID: 20590732
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes mellitus impairs the maturation of endothelial progenitor cells and increases the number of circulating endothelial cells in peripheral blood.
Lombardo MF; Iacopino P; Cuzzola M; Spiniello E; Garreffa C; Ferrelli F; Coppola A; Saccardi R; Piaggesi A; Piro R; Mannino D; Grossi G; Lauro D; Irrera G
Cytometry A; 2012 Oct; 81(10):856-64. PubMed ID: 22930579
[TBL] [Abstract][Full Text] [Related]
4. Arterial endothelial cells: still the craftsmen of regenerated endothelium.
Hagensen MK; Vanhoutte PM; Bentzon JF
Cardiovasc Res; 2012 Aug; 95(3):281-9. PubMed ID: 22652005
[TBL] [Abstract][Full Text] [Related]
5. Endothelial progenitor cells as a new agent contributing to vascular repair.
Miller-Kasprzak E; Jagodziński PP
Arch Immunol Ther Exp (Warsz); 2007; 55(4):247-59. PubMed ID: 17659378
[TBL] [Abstract][Full Text] [Related]
6. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.
Sen S; McDonald SP; Coates PT; Bonder CS
Clin Sci (Lond); 2011 Apr; 120(7):263-83. PubMed ID: 21143202
[TBL] [Abstract][Full Text] [Related]
7. Potential implications of vascular wall resident endothelial progenitor cells.
Ergün S; Tilki D; Hohn HP; Gehling U; Kilic N
Thromb Haemost; 2007 Nov; 98(5):930-9. PubMed ID: 18000595
[TBL] [Abstract][Full Text] [Related]
8. [Number and function of circulating endothelial progenitor cell in diabetics with different vascular complications].
Chen LL; Liao YF; Zeng TS; Li YM; Yu F; Li HQ
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1234-9. PubMed ID: 19595175
[TBL] [Abstract][Full Text] [Related]
9. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes.
Thum T; Fraccarollo D; Schultheiss M; Froese S; Galuppo P; Widder JD; Tsikas D; Ertl G; Bauersachs J
Diabetes; 2007 Mar; 56(3):666-74. PubMed ID: 17327434
[TBL] [Abstract][Full Text] [Related]
10. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.
Jung SY; Choi JH; Kwon SM; Masuda H; Asahara T; Lee YM
J Cell Biochem; 2012 May; 113(5):1478-87. PubMed ID: 22298358
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction in type 2 diabetes mellitus.
Avogaro A; Fadini GP; Gallo A; Pagnin E; de Kreutzenberg S
Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S39-45. PubMed ID: 16530129
[TBL] [Abstract][Full Text] [Related]
12. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Sorrentino SA; Bahlmann FH; Besler C; Müller M; Schulz S; Kirchhoff N; Doerries C; Horváth T; Limbourg A; Limbourg F; Fliser D; Haller H; Drexler H; Landmesser U
Circulation; 2007 Jul; 116(2):163-73. PubMed ID: 17592079
[TBL] [Abstract][Full Text] [Related]
13. Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes.
Kang L; Chen Q; Wang L; Gao L; Meng K; Chen J; Ferro A; Xu B
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):e47-56. PubMed ID: 19558529
[TBL] [Abstract][Full Text] [Related]
14. Vascular repair by endothelial progenitor cells.
Zampetaki A; Kirton JP; Xu Q
Cardiovasc Res; 2008 Jun; 78(3):413-21. PubMed ID: 18349136
[TBL] [Abstract][Full Text] [Related]
15. Emerging biology of vascular wall progenitor cells in health and disease.
Tilki D; Hohn HP; Ergün B; Rafii S; Ergün S
Trends Mol Med; 2009 Nov; 15(11):501-9. PubMed ID: 19828379
[TBL] [Abstract][Full Text] [Related]
16. Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease.
Dome B; Dobos J; Tovari J; Paku S; Kovacs G; Ostoros G; Timar J
Cytometry A; 2008 Mar; 73(3):186-93. PubMed ID: 18000872
[TBL] [Abstract][Full Text] [Related]
17. The decrement in circulating endothelial progenitor cells (EPCs) in type 2 diabetes is independent of the severity of the hypoadiponectemia.
Li M; Ho JC; Lai KW; Au KK; Xu A; Cheung BM; Lam KS; Tse HF
Diabetes Metab Res Rev; 2011 Feb; 27(2):185-94. PubMed ID: 21294240
[TBL] [Abstract][Full Text] [Related]
18. Relationships between vascular dysfunction, circulating endothelial progenitor cells, and psychological status in healthy subjects.
Chen H; Yiu KH; Tse HF
Depress Anxiety; 2011 Aug; 28(8):719-27. PubMed ID: 21681866
[TBL] [Abstract][Full Text] [Related]
19. Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases.
Brixius K; Funcke F; Graf C; Bloch W
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):705-10. PubMed ID: 17001208
[TBL] [Abstract][Full Text] [Related]
20. The glycocalyx and cardiovascular disease in diabetes: should we judge the endothelium by its cover?
Lemkes BA; Nieuwdorp M; Hoekstra JB; Holleman F
Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S3-10. PubMed ID: 22650222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
